Multiple Sclerosis Management: Current Clinical Approaches to Disease-Modifying Therapy

AbstractPurpose of ReviewThe treatment landscape for multiple sclerosis has evolved and expanded significantly over the past 30  years, with now over 20 disease-modifying therapies available on the market. This review is meant to provide an update on disease-modifying therapy management.Recent FindingsMultiple sclerosis presents heterogeneously and it is impossible to predict the disease course on an individual basis. However, there are some clinical and radiographic findings which suggest a more severe and disabling course warranting high-efficacy treatment.SummaryTreatment is chosen based on shared decision-making between the patient and provider based on various clinical, radiographic, safety, and socioeconomic factors. Multiple emerging therapies are currently being studied to address the progressive and neurodegenerative component of MS.
Source: Current Physical Medicine and Rehabilitation Reports - Category: Rehabilitation Source Type: research